Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis
Status:
Completed
Trial end date:
2016-12-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish if BMS-986202 is safe and effective at treating
autoimmune diseases such as psoriasis. BMS-986202 which has shown some promise in preclinical
studies for inhibiting autoimmune conditions such as psoriasis. This study will be the first
time this drug is given to humans.